絞り込み

16610

広告

「"Till BG "[Author]」の検索結果

43件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Outcomes of Patients with Large B-Cell Lymphomas and Progressive Disease Following CD19-Specific CAR T-Cell Therapy.

Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United States.

The response to lymphodepletion impacts PFS in aggressive non-Hodgkin lymphoma patients treated with CD19 CAR-T cells.

Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR-T cells.

Eligibility for Car T-cell Therapy: An Analysis of Selection Criteria and Survival Outcomes in Chemorefractory DLBCL.

Modified VR-CAP, Alternating With Rituximab and High-dose Cytarabine: An Effective Pre-transplant Induction Regimen for Mantle Cell Lymphoma.

Construction and functional characterization of a fully human anti-CD19 chimeric antigen receptor (huCAR)-expressing primary human T cells.

Predictive and therapeutic biomarkers in chimeric antigen receptor T-cell therapy: A clinical perspective.

Bendamustine, etoposide, and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in non-Hodgkin lymphoma.

Maintenance Therapy in Diffuse Large B Cell Lymphoma and Mantle Cell Lymphoma.

Preclinical Optimization of a CD20-specific Chimeric Antigen Receptor Vector and Culture Conditions.

CD38 bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B cell malignancies.

Total Body Irradiation is Safe and Similarly Effective to Chemotherapy-Only Conditioning in Autologous Stem Cell Transplantation for Mantle Cell Lymphoma Patients.

Venetoclax Synergizes with Radiotherapy for Treatment of B cell Lymphomas.

Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.

Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas.

Comparative analysis of bispecific antibody and streptavidin-targeted radioimmunotherapy for B cell cancers.

Prospects for chimeric antigen receptor (CAR) γδ T cells: a potential game changer for adoptive T cell cancer immunotherapy.

Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma.

Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T Cells in the Presence of Rituximab.

  1. 1
  2. 2
  3. 3
Sort by
※並べ替えは表示に時間がかかります